Showing results (91-100 of 126) with videos related to
Sort By:
Pageof 13
Journal of Psychiatric Practice|September 26, 2006
Long-term lamotrigine plus lithium for bipolar disorder: One year outcomeS Nassir Ghaemi, Eric Schrauwen, Jeffry Klugman, et al.Journal of Affective Disorders|May 27, 2014
Koukopoulos׳ diagnostic criteria for mixed depression: a validation studyGabriele Sani, Paul A Vöhringer, Flavia Napoletano, et al.Politics and the Life Sciences : the Journal of the Association for Politics and the Life Sciences|September 18, 2024
Cognitive decline and political leadershipSteven Gong, Zifeng P Hu, S Nassir Ghaemi, et al.Journal of Clinical Psychopharmacology|April 18, 2015
A 13-week, randomized double-blind, placebo-controlled, cross-over trial of ziprasidone in bipolar spectrum disorderAshwin A Patkar, Chi-Un Pae, Paul A Vöhringer, et al.International Clinical Psychopharmacology|September 30, 2005
Rapid titration versus conventional titration of quetiapine in the treatment of bipolar mania: a preliminary trialChi-Un Pae, S Nassir Ghaemi, Tae-Suk Kim, et al.Clinical Psychopharmacology and Neuroscience : the Official Scientific Journal of the Korean College of Neuropsychopharmacology|January 26, 2023
COVID-19 Impact on the Italian Community-based System of Mental Health Care: Reflections and Lessons Learned for the FutureAndrea Amerio, Eleonora Vai, Edoardo Bruno, et al.The Journal of Clinical Psychiatry|October 27, 2007
Self-reported history of manic/hypomanic switch associated with antidepressant use: data from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD)Christine J Truman, Joseph F Goldberg, S Nassir Ghaemi, et al.International Journal of Bipolar Disorders|October 13, 2022
Clinical research diagnostic criteria for bipolar illness (CRDC-BP): rationale and validityS Nassir Ghaemi, Jules Angst, Paul A Vohringer, et al.Journal of Affective Disorders|June 24, 2014
International prescribing patterns for mood illness: the International Mood Network (IMN)Sivan Mauer, Rami Alahmari, Paul A Vöhringer, et al.Journal of Clinical Psychopharmacology|May 15, 2009
A double-blind, placebo-controlled pilot study of galantamine to improve cognitive dysfunction in minimally symptomatic bipolar disorderS Nassir Ghaemi, William S Gilmer, Robert T Dunn, et al.Pageof 13